Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study (Q35848253)

10 August 2017

Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study (English)

1 reference

10 August 2017

0 references

1 reference

2

Russell E Ware

1 reference

10 August 2017

Jane S Hankins

1

1 reference

10 August 2017

Zora R Rogers

3

1 reference

10 August 2017

Lynn W Wynn

4

1 reference

10 August 2017

Peter A Lane

5

1 reference

10 August 2017

J Paul Scott

6

1 reference

10 August 2017

Winfred C Wang

7

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

10 August 2017

1 reference

10 August 2017

106

1 reference

10 August 2017

7

1 reference

10 August 2017

2269-2275

1 reference

Malignancy in patients with sickle cell disease

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Partial splenectomy in children under 4 years of age with hemoglobinopathy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

First report of reversal of organ dysfunction in sickle cell anemia by the use of hydroxyurea: splenic regeneration.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Chemical and functional analysis of hydroxyurea oral solutions.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Hydroxyurea-induced splenic regrowth in an adult patient with severe hemoglobin SC disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Scintigraphic follow-up of the effects of therapy with hydroxyurea on splenic function in patients with sickle cell disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Five years of experience with hydroxyurea in children and young adults with sickle cell disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Functional asplenia in hemoglobin SC disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895275

Hydroxyurea therapy in children severely affected with sickle cell disease

24 September 2018

1 reference

12 December 2020

The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease

1 reference

12 December 2020

Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial

1 reference

12 December 2020

Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia

1 reference

12 December 2020

Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease

1 reference

12 December 2020

Hydroxyurea therapy for diverse pediatric populations with sickle cell disease

1 reference

12 December 2020

Functional asplenia in sickle-cell anemia

1 reference

12 December 2020

Post-natal decline of fetal haemoglobin in homozygous sickle cell disease: relationship to parenteral Hb F levels

1 reference

12 December 2020

Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?

1 reference

12 December 2020

Influence of sickle hemoglobinopathies on growth and development

1 reference

12 December 2020

Recruitment in the Cooperative Study of Sickle Cell Disease (CSSCD)

1 reference

12 December 2020

Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia

1 reference

12 December 2020

Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group

1 reference

12 December 2020

A case for developing North-South partnerships for research in sickle cell disease

1 reference

12 December 2020

Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin

1 reference

12 December 2020

Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with sickle cell disease

1 reference

12 December 2020

Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children

1 reference

12 December 2020

10.1182/BLOOD-2004-12-4973

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

16172253

1 reference